DiogenX

DiogenX

DiogenX

DiogenX, a Marseille, France-based preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators for the treatment of type one diabetes (T1D).
Founded
2019
Raised
$4.5M
Follow us
Latest funding
$4,500,000
Seed fund - 2020
Boehringer Ingelheim Venture Fund JDRF T1D Fund Advent France Biotechnology (AFB)
Team Size
1–10
Employees
Location
Headquarters
$4,500,000 Seed fund
FinSMEs

DiogenX Raises €4.5M in Seed Financing